Off-Pump Coronary Artery Bypass Grafting and Stroke-Exploratory Analysis of the GOPCABE Trial and Methodological

Wilko Reents1, Michael Zacher1, Jochen Boergermann2

  • 1Herzchirurgie, Herz- und Gefäßklinik Bad Neustadt, Bad Neustadt, Germany.

Insights

Off-pump coronary artery bypass grafting (CABG) did not show lower stroke rates compared to on-pump CABG in elderly patients. Surgical aortic manipulation also did not significantly impact stroke rates in the off-pump group.

Area of Science:

  • Cardiovascular Surgery
  • Neurosurgery
  • Geriatric Medicine

Background:

  • Coronary artery bypass grafting (CABG) is a common surgical procedure.
  • Off-pump CABG aims to reduce adverse events compared to traditional on-pump CABG.
  • Stroke is a significant concern following cardiac surgery.

Purpose of the Study:

  • To investigate the impact of surgical aortic manipulation on stroke rates in off-pump CABG.
  • To compare stroke rates between off-pump and on-pump CABG in elderly patients.
  • To analyze stroke incidence in relation to different aortic manipulation techniques during off-pump CABG.

Main Methods:

  • Post-hoc analysis of the German Off-Pump Coronary Artery Bypass Grafting in Elderly patients trial.
  • Comparison of stroke rates within 30 days post-surgery between off-pump and on-pump CABG groups.
  • Stratification of stroke rates within the off-pump group based on degree of aortic manipulation (tangential clamping, clampless device, no manipulation).
  • Aggregate analysis of stroke rates from four major trials involving over 10,000 patients.

Main Results:

  • No significant difference in 30-day stroke rates between off-pump (2.2%) and on-pump (2.7%) CABG (OR 0.83).
  • Within the off-pump group, varying degrees of aortic manipulation did not yield significantly different stroke rates.
  • Aggregate analysis of over 10,000 patients confirmed comparable stroke rates for both techniques (off-pump 1.4%, on-pump 1.7%).

Conclusions:

  • Off-pump CABG does not appear to reduce stroke rates compared to on-pump CABG in recent trials.
  • Potential benefits of off-pump CABG may be counteracted by surgical complexity and multifactorial stroke mechanisms.
  • Further research is needed to fully elucidate the role of surgical technique in perioperative stroke prevention.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K